Correlation Between Medipharm Labs and Canntab Therapeutics
Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medipharm Labs Corp and Canntab Therapeutics Limited, you can compare the effects of market volatilities on Medipharm Labs and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and Canntab Therapeutics.
Diversification Opportunities for Medipharm Labs and Canntab Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Medipharm and Canntab is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and Canntab Therapeutics go up and down completely randomly.
Pair Corralation between Medipharm Labs and Canntab Therapeutics
Assuming the 90 days horizon Medipharm Labs is expected to generate 38.88 times less return on investment than Canntab Therapeutics. But when comparing it to its historical volatility, Medipharm Labs Corp is 6.24 times less risky than Canntab Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Canntab Therapeutics Limited is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1.76 in Canntab Therapeutics Limited on November 2, 2024 and sell it today you would lose (1.75) from holding Canntab Therapeutics Limited or give up 99.43% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
Medipharm Labs Corp vs. Canntab Therapeutics Limited
Performance |
Timeline |
Medipharm Labs Corp |
Canntab Therapeutics |
Medipharm Labs and Canntab Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Medipharm Labs and Canntab Therapeutics
The main advantage of trading using opposite Medipharm Labs and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.Medipharm Labs vs. Pharmacielo | Medipharm Labs vs. Blueberries Medical Corp | Medipharm Labs vs. Flora Growth Corp | Medipharm Labs vs. Stem Holdings |
Canntab Therapeutics vs. Bionoid Pharma | Canntab Therapeutics vs. CTT Pharmaceutical Holdings | Canntab Therapeutics vs. Alterola Biotech | Canntab Therapeutics vs. HLS Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |